عنوان
پدید آورنده
موضوع
رده
HD9666.9.M4 V34 2006eb
HD9666
.
9
.
M4
V34
2006eb
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
0511168888
(Number (ISBN
0511169310
(Number (ISBN
0511616864
(Number (ISBN
6610436991
(Number (ISBN
9780511168888
(Number (ISBN
9780511169311
(Number (ISBN
9780511616860
(Number (ISBN
9786610436996
Erroneous ISBN
0521683831
Erroneous ISBN
0521864550
Erroneous ISBN
1280436999
Erroneous ISBN
9780521683838
Erroneous ISBN
9780521864558
Erroneous ISBN
9781280436994
NATIONAL BIBLIOGRAPHY NUMBER
Number
b769936
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
The moral corporation /
General Material Designation
[Book]
First Statement of Responsibility
P. Roy Vagelos, Louis Galambos.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
New York :
Name of Publisher, Distributor, etc.
Cambridge University Press,
Date of Publication, Distribution, etc.
2006.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (1 volume)
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
The puzzle -- The professional path -- Turn around -- New drugs and public safety -- Corporate grooming -- Winning in global competition -- Prices and the public interest -- Moral leadership -- Afterwards.
0
SUMMARY OR ABSTRACT
Text of Note
Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a physician and scientist, he had to learn how to run a successful business while holding to the highest principles of ethical behavior. He was not always successful. He and his co-author explain where and why he failed to achieve his goals and carefully analyze where he succeeded.
OTHER EDITION IN ANOTHER MEDIUM
Title
Moral corporation.
International Standard Book Number
0521683831
PERSONAL NAME USED AS SUBJECT
Vagelos, P. Roy.
Vagelos, P. Roy.
CORPORATE BODY NAME USED AS SUBJECT
Merck & Co-- Management.
Merck & Co.
TOPICAL NAME USED AS SUBJECT
Business ethics.
Pharmaceutical industry-- Moral and ethical aspects-- United States.
Social responsibility of business.
BUSINESS & ECONOMICS-- Corporate & Business History.
BUSINESS & ECONOMICS-- Infrastructure.
Business ethics.
Management.
Pharmaceutical industry-- Moral and ethical aspects.
Social responsibility of business.
GEOGRAPHICAL NAME USED AS SUBJECT
United States.
7
(SUBJECT CATEGORY (Provisional
BUS-- 032000
BUS-- 077000
KNDP
DEWEY DECIMAL CLASSIFICATION
Number
B
Edition
22
LIBRARY OF CONGRESS CLASSIFICATION
Class number
HD9666
.
9
.
M4
Book number
V34
2006eb
PERSONAL NAME - PRIMARY RESPONSIBILITY
Vagelos, P. Roy.
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Galambos, Louis.
ORIGINATING SOURCE
Date of Transaction
20201206161535.0
Cataloguing Rules (Descriptive Conventions))
pn
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
